老挝南部私营部门抗生素伪造与劣质药品随机调查
2012年在老挝南部五省通过神秘顾客分层随机抽样147家药店,用HPLC测定909份样本中9种抗生素API含量。所有样本均含标示API,未发现伪造,但19.6%样本单位含量超出90%-110%标示范围,60.2%样本不符合国际药典含量均匀度限值。
要点
- 未发现伪造抗生素,但劣质抗生素普遍存在
- 19.6%样本单位API含量超出90%-110%标示范围
- 60.2%样本不符合国际药典含量均匀度限值
核心结论
- 老挝南部私营部门未发现伪造抗生素,但劣质抗生素普遍存在,可能降低疗效并影响细菌感染控制。
研究设计与样本
- 2012年采用神秘顾客法在老挝南部五省10个县分层随机抽样147家药店,HPLC测定909份样本中9种API含量。
主要发现
- 所有分析样本均含标示API,未发现伪造证据。
- 除1份样本外,所有单位API含量在标示量的75%-125%之间。
- 19.6%(201/1025)样本单位含量超出90%-110%标示范围,60.2%(617/1025)不符合国际药典含量均匀度限值。
- 阿莫西林67.1%(151)样本单位含量超上限,环丙沙星58.8%(10)和氧氟沙星57.4%(39)次之。
- 头孢曲松57.1%(4)、甲氧苄啶51.6%(64)和磺胺甲噁唑34.7%(43)样本API含量偏低最多,%API在标示生产国和生产商间差异显著。
关键数值与推荐
- 单位API含量在标示量90%-110%范围内为合格,19.6%(201/1025)样本超出此范围。
- 国际药典含量均匀度限值范围内为合格,60.2%(617/1025)样本超出此范围。
- 单位API含量在标示量75%-125%范围内视为未发现伪造,除1份样本外均满足。
临床怎么用
- 临床应关注老挝私营部门抗生素质量,劣质药品可能降低疗效,影响细菌感染治疗和抗菌药物耐药控制。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: In 2012, a stratified random survey, using mystery shoppers, was conducted to investigate the availability and quality of antibiotics sold to patients in the private sector in five southern provinces of the Lao People's Democratic Republic (Laos). METHODS: A total of 147 outlets were sampled in 10 districts. The active pharmaceutical ingredient (API) content measurements for 909 samples, including nine APIs (amoxicillin, ampicillin, ceftriaxone, ciprofloxacin, doxycycline, ofloxacin, sulfamethoxazole, tetracycline and trimethoprim), were determined using HPLC. RESULTS: All the analysed samples contained the stated API and we found no evidence for falsification. All except one sample had all the units tested with %API values between 75% and 125% of the content stated on the label. However, we identified the presence of substandard antibiotics: 19.6% (201/1025) of samples had their units outside the 90%-110% content of the label claim and 60.2% (617/1025) of the samples had units outside of the International Pharmacopoeia uniformity of content limit range. Amoxicillin had a high number of samples [67.1% (151)] with units above the limit range, followed by ciprofloxacin [58.8% (10)] and ofloxacin [57.4% (39)]. Ceftriaxone, trimethoprim and sulfamethoxazole had the highest number of samples with low API content: 57.1% (4), 51.6% (64) and 34.7% (43), respectively. Significant differences in %API were found between stated countries of manufacture and stated manufacturers. CONCLUSIONS: With the global threat of antimicrobial resistance to patient outcomes, greater understanding of the role of poor-quality antibiotics is needed. Substandard antibiotics will have reduced therapeutic efficacy, impacting public health and control of bacterial infections.
引用
- Tabernero P, Swamidoss I, Mayxay M, et al. A random survey of the prevalence of falsified and substandard antibiotics in the Lao PDR. J Antimicrob Chemother. 2019. PMID: 31049576. doi:10.1093/jac/dkz164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。